Daiwa-Securities-Group

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
1,307
Total Value
15007955
Accession Number
0001481045-25-000006
Form Type
13F-HR
Manager Name
Daiwa-Securities-Group
Data Enrichment
93% identified
1,218 identified89 unidentified

Holdings

1,307 positions • $15.0M total value
Manager:
Search and click to pin securities to the top
Page 64 of 64
Oric Pharmaceuticals, Inc.
Shares:249
Value:$1.0K
% of Portfolio:0.0% ($1.0K/$15.0M)
RIGEL PHARMACEUTICALS INC
Shares:80
Value:$1.0K
% of Portfolio:0.0% ($1.0K/$15.0M)
921946885
Shares:18
Value:$1.0K
% of Portfolio:0.0% ($1.0K/$15.0M)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Shares:909
Value:$1.0K
% of Portfolio:0.0% ($1.0K/$15.0M)
SIGA TECHNOLOGIES INC
Shares:270
Value:$1.0K
% of Portfolio:0.0% ($1.0K/$15.0M)
Vanda Pharmaceuticals Inc.
Shares:191
Value:$1.0K
% of Portfolio:0.0% ($1.0K/$15.0M)
Mind Medicine (MindMed) Inc.
Shares:242
Value:$1.0K
% of Portfolio:0.0% ($1.0K/$15.0M)
LEXICON PHARMACEUTICALS, INC.
Shares:1.4K
Value:$1.0K
% of Portfolio:0.0% ($1.0K/$15.0M)
Monte Rosa Therapeutics, Inc.
Shares:203
Value:$1.0K
% of Portfolio:0.0% ($1.0K/$15.0M)
Neumora Therapeutics, Inc.
Shares:533
Value:$1.0K
% of Portfolio:0.0% ($1.0K/$15.0M)
Olema Pharmaceuticals, Inc.
Shares:224
Value:$1.0K
% of Portfolio:0.0% ($1.0K/$15.0M)
MACROGENICS INC
Shares:209
Value:$0
% of Portfolio:0.0% ($0/$15.0M)
Lyell Immunopharma, Inc.
Shares:917
Value:$0
% of Portfolio:0.0% ($0/$15.0M)
Editas Medicine, Inc.
Shares:277
Value:$0
% of Portfolio:0.0% ($0/$15.0M)
Biomea Fusion, Inc.
Shares:109
Value:$0
% of Portfolio:0.0% ($0/$15.0M)
Tango Therapeutics, Inc.
Shares:355
Value:$0
% of Portfolio:0.0% ($0/$15.0M)
Terns Pharmaceuticals, Inc.
Shares:151
Value:$0
% of Portfolio:0.0% ($0/$15.0M)
Alector, Inc.
Shares:277
Value:$0
% of Portfolio:0.0% ($0/$15.0M)
PLIANT THERAPEUTICS, INC.
Shares:196
Value:$0
% of Portfolio:0.0% ($0/$15.0M)